Background People with HIV (PWH) in Latin America are at a greater risk of developing
comorbidities due to the increasing burden of obesity and metabolic syndrome in the region …

Metabolic syndrome (MS), a group of interrelated risk factors for cardiovascular diseases
(CVD) and type 2 diabetes, has been increasingly reported among HIV-infected patients …

Aim: To assess whether lipid abnormalities in patients with HIV are stable over time.
Patients: The perinatally HIV-infected cohort at a medium-sized urban US teaching hospital …

Background Insulin resistance is frequent in human immunodeficiency virus (HIV) infection
and may be related to antiretroviral therapy. Cytokines secreted by adipose tissue …

Objectives. We determined metabolic syndrome (MetS) prevalence and assessed the
agreement between different diagnostic criteria in HIV‐infected South Africans. Method. A …

Objective: To determine the extent and degree of abnormalities of serum lipids, glucose
homeostasis and abdominal adipose tissue distribution in protease inhibitor (PI)-treated and …

Introduction The incidence of metabolic syndrome (MetS) in people living with HIV is
significantly higher than in people without HIV. MetS is not only a major driver of …

Background: Dyslipidemia and central obesity are the main components of metabolic
syndrome, which represent important risk factors for cardiovascular diseases in people living …

Objectives: To estimate the prevalence of and identify risk factors for lipodystrophy syndrome
(LS) and body fat abnormality in a population of HIV-infected children and adolescents …

OBJECTIVE: To evaluate the prevalence of and the associated factors for metabolic
syndrome (MS) among Latin American HIV-infected patients receiving antiretroviral therapy …